UCSF

Plan B under review again by the FDA

In light of the US Food and Drug Administration (FDA) July 31, 2006 announcement that it is proceeding to work toward making emergency contraception, known as Plan B, a non-prescription product for women ages 18 and older, two UCSF School of Pharmacy clinical faculty members answer questions about the contraceptive and surrounding policy issues. Lorie Rice, MPH, is an expert on pharmacy law and ethics, and Shareen El-Ibiary, PharmD, is an expert on women's health. Nine states, including California, currently allow the dispensing of Plan B without a prescription.

Full story

FDA Announces Plan to Review Plan B Contraceptive for Women 18 and Over

More

FDA Announces Framework for Moving Emergency Contraception Medication to Over-the-Counter Status

Tags

Category:
Sites:
School of Pharmacy, Department of Clinical Pharmacy, PharmD Degree Program

About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.